Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- ChecktodayChange DetectedThe revision tag was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's revision history. This does not reflect changes to the study details or results.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, indicating a minor platform/content release change without altering the study details.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. No changes to study content or user-facing information.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision note updated: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page shows a minor system revision update from v3.4.1 to v3.4.2, with no changes to the study information, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.